Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DepoTech withdraws MAA for Savedar for solid tumor indication

Oct. 19, 1998

Melatonin prevents doxorubicin-induced cardiotoxicity in rat model

Oct. 19, 1998

New drug delivery technology soon to enter clinical testing

Oct. 19, 1998

Wayne Hughes Institute develops potent new agent for breast cancer

Oct. 16, 1998

Gene for Rx, Dx of liver cancer available for licensing from RCT

Oct. 16, 1998

Scientists at Cell Therapeutics disclose new signal transduction inhibitors

Oct. 16, 1998

New animal model of bone metastasis developed at AntiCancer

Oct. 16, 1998

Novel anticancer agent from ProScript moves into clinical testing

Oct. 16, 1998

Taxol combination therapy approved in France for NSCLC indication

Oct. 16, 1998

BioNumerik publishes preclinical data on BNP-7787 in cancer journal

Oct. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...